My Own Questions Flashcards
Potent… By IV administration, epinephrine induces peak response proportional to dose..
True
Factor/factors associated with characterizing blood pressure increases secondary to epinephrine administration:
Increase in blood pressure is due in ____
Increase in blood pressure is due in _____
Increased ventricular contractility (also known as a positive inotropic effect)
due in part to increased heart rate (also known as positive chronotropic effect)
T/FFollowing IV epinephrine administration,an increased blood pressure is observed in part because of drug-induced vasoconstriction, particularly in skin, mucosal, and renal precapillary resistance vessels.
True
T/F Following IV epinephrine administration, the pulse rate is initially increased but may then be decreased as a result of a compensatory cholinergic, vagal effect triggered by the baroreceptor reflex.
True
T/F Absorption of epinephrine following subcutaneous (s. c.) injection: slows result of local vasoconstrictor activity mediated by β receptor activation; if false why?
False; It is via ALPHA receptor
Administration of this agent by the intravenous infusion route is likely to cause an immediate reduction in pulse rate _____
norepinephrine
IV administration of this agent is LIKELY to result in an extended elevation in heart rate_______
ISOPROTERENOL
IV administration of this agent is MOST likely to induce both in elevation in systolic and diastolic pressure_____
Norepinephrine
IV administration of this agent is MOST likely to result in an extended elevation in vascular peripheral resistance_____
Norepinephrine
IV administration of this agent is MOST likely to cause the most profound decrease in diastolic blood pressure.
ISOPROTERENOL
IV administration of this agent is LEAST likely to cause an increase in systolic blood pressure
ISOPROTERENOL
IV administration of this agent is most likely to result in the most profound decrease in peripheral resistance______
ISOPROTERENOL
T/F At epinephrine doses that increased renal vascular resistance while having limited effects on mean arterial pressure renin secretion is increased.
True
T/F Epinephrine administration tends to increase arterial and venous pulmonary pressures.
True
T/F Factor(s) responsible for elevated pulmonary pressures due to epinephrine:
Direct pulmonary vasoconstriction
Redistribution of blood from the systemic circulation as a result of systemic vasoconstriction to the pulmonary circulation.
True Both
T/F Administration of high epinephrine concentrations may induce pulmonary edema secondary to high pulmonary capillary filtration pressure as well as possible effects on capillaries.
True
T/F Usually, under physiological circumstances, coronary blood flow:
Increased by epinephrine
Increased by cardiac sympathetic stimulation
True both
T/ F Epinephrine increases the slope of phase 4 depolarization, thus increasing heart rate.
True
Epinephrine on MYOCARDIAL SYSTOLE
- Systole is shorter/longer ?
- Systole exhibits increased contractility (more power)
- Cardiac output is increased
- Cardiac efficiency, described as work performed relative to oxygen consumed, is reduced..
shorter
Associated with higher doses of epinephrine administered:
PVCs
Ventricular Arrhythmias
T/F Epinephrine administration usually shortens the human AV nodal refractory.
True
β-adrenergic, non-selective blocker.
propranolol
Epinephrine-induced in ventricular arrhythmias: The likelihood of these arrhythmias may be enhanced as a result of reduced sinus rate and AV conduction secondary to increased vagal nerve activity.
reduced sinus rate and AV conduction secondary to increased vagal nerve activity.
Dependent on state of gestation, phase of sexual cycle and dose
Uterine Smooth muscle response to epinephrine
Epinephrine inhibits serotonin contraction during last month of pregnancy.
Epinephrine and bladder smooth muscle effect(s):
Detrusor muscle _____ _due to _____
_______of trigone and sphincter due to ______receptor
- Detrusor muscle relaxation due to β-adrenergic receptor activation.
- Contraction of trigone and sphincter muscle as a result of α-adrenergic receptor subtype activation.
Sympathetic effect is on radial muscle
Contraction
Autonomic effect: ciliary muscle of the eye:
Relaxation for far vision is the sympathetic-mediated response (β2)
Parasympathetic effect is contraction for near vision (M2, M3 muscarinic receptor subtype mediated)
T/F The parasympathetic action is to decrease conduction velocity and to promote blockade at the AV node.
True
The parasympathetic effect is the predominant action on which ORGAN
HEART
T/F The parasympathetic effect is to reduce contractility and decreased the action potential duration. With respect to contractility, the parasympathetic effect dominates.
True
Epinephrine beneficial effect(s) in asthma:
- Decreasing bronchial secretion
- Decreasing mucosal congestion
- Possible reduction in antigen-induced inflammatory mediator release from mast cells
- Direct bronchodilator effects
true
Inhibit insulins secretion
Alpha 2
Promote insulin secretion
Beta 2
T/F
The predominant effect of epinephrine with respect insulin secretion is mediated by activation of α2 receptors the activation of which inhibits insulin secretion.
T/F Epinephrine increases hematocrit
True
T/F Administration of epinephrine and selective β2 agonists tends increase physiological tremor.
True
Epinephrine effect(s) on plasma potassium:
- Epinephrine administration _______ plasma potassium.
- Epinephrine effects on plasma potassium are likely mediated by ______________________________
decreases; activation of β2 adrenergic receptors.
Epinephrine administered SYSTEMATICALLY result in substantial _______ and ________ activity.
sweating and pilomotor activity.
Very potent beta adrenergic receptor agonists with minimal effects on alpha adrenergic receptors:
ISOPROTERENOL
Sympathomimetic due to inhibition of transmitter uptake at noradrenergic synapses:
COCAINE
Beta-2 selective agonist– typically administered by aerosol for asthma management:
Albuterol
Beta-2 selective agonist– typically administered by aerosol for asthma management:
PHENTOLAMINE